Hualan Biological Engineering (SZSE:002007) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Additional Paid-In Capital?

Hualan Biological Engineering's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥72 Mil) but then stayed the same from Dec. 2023 (¥72 Mil) to Mar. 2024 (¥0 Mil).

Hualan Biological Engineering's annual additional paid-in capital stayed the same from Dec. 2021 (¥28 Mil) to Dec. 2022 (¥28 Mil) but then increased from Dec. 2022 (¥28 Mil) to Dec. 2023 (¥72 Mil).

Hualan Biological Engineering Additional Paid-In Capital Historical Data

The historical data trend for Hualan Biological Engineering's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Additional Paid-In Capital Chart

Hualan Biological Engineering Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

444.52

28.24

71.90

Hualan Biological Engineering Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	28.24	-	71.90	-

Hualan Biological Engineering Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Hualan Biological Engineering Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Hualan Biological Engineering (SZSE:002007) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

No. A1 Hualan Avenue, Henan Province, Xinxiang, CHN, 453003

Website

http://www.hualanbio.com

Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

Hualan Biological Engineering (SZSE:002007) Headlines

No Headlines